Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma

James B. Berenson*, Sundar Jagannath, Bart Barlogie, David T. Siegel, Raymond Alexanian, Paul G. Richardson, David Irwin, Melissa Alsina, S. Vincent Rajkumar, Gordon Srkalovic, Seema Singhal, Steven Limenitani, Ruben Niesvizky, Dixie L. Esseltine, Elizabeth Trehu, David P. Schenkein, Kenneth Anderson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

102 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences